Comprehensive analysis of biomarkers in patients with pulmonary arterial hypertension

Comprehensive analysis of biomarkers in patients with pulmonary arterial hypertension - Comprehensive analysis of biomarkers in patients with pulmonary arterial hypertension

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039828

Enrollment

200

Registered

2020-03-16

Start date

2020-02-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary arterial hypertension

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with pulmonary arterial pulmonary hypertension registered or scheduled to be registered in JAPHR

Exclusion criteria

Exclusion criteria: Patients who have received biologics within 3 months before blood collection for this study Patients who withdrew consent to participate in JAPHR Patients who refused to participate in this study Judged by the investigator

Design outcomes

Primary

Measure	Time frame
Identification of Immune-responsive phenotyp	—

Countries

Japan

Contacts

Public ContactYuichi Tamura

International University of Health and Welfare, Mita Hospital Cardiovascular internal medicine

u1@iuhw.ac.jp03-3451-8121

Outcome results